drugset / Trial / NCT03206463
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
RandomizedCrossoverQuadruple-blindBasic science
Summary
The overarching goal of this study is to characterize the acute cognitive and psychophysiological effects of the main psychoactive constituent of cannabis, 9-delta-tetrahydrocannabinol (THC) in individuals with euthymic bipolar disorder (BD), and to begin probing the mechanisms that may underlie its effects in this illness. This study is expected to contribute to a better characterization of specific effects of THC in individuals with BD compared to healthy controls (HC).
Timeline
- Start
- 2017-08-01
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 2 mg | Inhaled |
| Subject | Dronabinol | Other / unclassified | 4 mg | Inhaled |